Register by July 10, 2009 and SAVE! up to $350 


Cambridge Healthtech Institute is pleased to present ADAPT 2009, Accelerating Development & Advancing Personalized Therapy. This event features eight meetings with in-depth coverage of Clinical Trials, Personalized Medicine, Cancer Therapy, and Biomarker Development. This event was developed as the primary platform where these currently disparate groups can come together, advance therapeutics, as well as tackle the challenges of the inevitable next chapter, personalized medicine. From Global pharmaceutical companies to small biotechs, universities, hospitals, and individuals the need to ADAPT is imperative to survive and thrive in today’s...tomorrow’s marketplace.

September 22: Pre-Conference Short Course
Biomarker Assay Development and Validation

Third Annual
Adaptive Clinical Trial Designs
Managing Complexity for Successful Implementation
September 22-24

Third Annual
Clinical Biomarkers
Optimizing Drug Development
September 24-25

September 22: Pre-Conference Short Course
Next-Generation Technologies Enabling Personalized Medicine

Inaugural
Personalized Medicine
Delivering on the Promise
September 22-24

Inaugural
Targeted Therapy 
Towards Individualized Cancer Treatment
September 24-25

September 22: Pre-Conference Short Course
Novel Cancer Biomarkers

Second Annual
Translational Cancer Medicine 
Optimizing Oncology Drug and Diagnostic Development
September 22-24

Inaugural
Circulating Tumor Cells 
Shaping the Future of Cancer Care
September 24-25

September 22: Pre-Conference Short Course
Biomarker Validation

Third Annual
Biomarker Data Analysis 
Integrating Biomarker Data and Establishing Biological and Clinical Relevance
September 22-24

Seventh Annual
Protein Biomarkers 
Overcoming Translational Challenges
September 24-25


KEYNOTE SPEAKERS
:

Barrett_Carl J. Carl Barrett
VP and Global Head
Oncology Translational Medicine, Novartis

NICHOLAS_DRACOPOLI Nicholas C. Dracopoli
VP, Biomarkers, Centocor R&D
Johnson & Johnson

Feuerstein_Giora Giora Feuerstein
AVP, Head, Discovery Translational Medicine
Wyeth Research

Stephen_Friend  Stephen H. Friend
President
Sage

Ratain_Mark  Mark J. Ratain
Chairman, Clinical Pharmacology and
Pharmacogenomics
Cancer Research Center, Univ. Chicago

Roses_Allen  Allen D. Roses
Director, Deane Drug Discovery Institute
Duke Univ. School of Medicine

Doug Throckmorton Douglas C. Throckmorton
Deputy Director, Center for Drug Evaluation and Research
U.S. Food and Drug
Administration


 

For more information, please contact:
Julia Boguslavsky, Executive Director, Conferences
E-mail: juliab@healthtech.com

For sponsorship information, please contact:
Ilana Quigley, Business Development
Phone: 781-972-5457; E-mail: iquigley@healthtech.com

BiomarkerWebinarsSm

 

Corporate Sponsors

Agilent resized

almac

ariadne new

BioFortis 130 dpi

EMD Novagen

Ingenuity

Meso Scale
Metanomics

Monarch

NextGen Sciences

Tasella

Thomson Scientific

Lead Sponsoring Publications:

http://www.biomarkerworldcongress.com/logos/Biomarkers_in_Medicine.jpg

Bio-IT World

eCliniqua

Journal of Biological Markers

The Scientist


Sponsoring Organization

http://www.chicorporate.com/uploadedImages/Adapt/Springer

 

Additional Media Partners

 

Consumer Genomics

Molecular Diagnostics

Cambridge Healthtech Institute  |  250 First Avenue, Suite 300  |  Needham MA 02494  |   phone: 781-972-5400  |   fax: 781-972-5425 chi@healthtech.com